VEGFA and prostate cancer: We found that the expression levels of miR-183-96-182 as well as VEGF, a known hypoxia responsive gene, were upregulated in PC-3 prostate cancer cells under the 1% O2 culture condition (Fig. 1a) or after hypoxia-mimetic agent deferoxamine (DFO) treatment (Fig. 1b).